/
/
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
This content is Free Access.
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
9,367 Views
•
12:09 min
•
February 28, 2019
DOI:
1Department of Microbiology and Immunology, Yong Loo Lin School of Medicine,National University of Singapore, 2Immunology Programme, Life Sciences Institute,National University of Singapore, 3Emerging Infectious Diseases Program,Duke-NUS Graduate Medical School, 4Singapore Immunology Network,A*STAR, 5NUS Graduate School for Integrative Sciences and Engineering (NGS),National University of Singapore, 6Department of Immunology, Wright-Fleming Institute,Imperial College London
Read Article
Cite this Article
Zhao, X., Hamidinia, M., Choo, J. A. L., Too, C. T., Ho, Z. Z., Ren, E. C., Bertoletti, A., MacAry, P. A., Gould, K. G., Brzostek, J., Gascoigne, N. R. Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation. J. Vis. Exp. (144), e59126, doi:10.3791/59126 (2019).
Copy